Loading clinical trials...
Loading clinical trials...
Sleep Disordered Breathing and Blood Glucose Control in Type 2 Diabetes
The hypothesis of this study is: sleep disordered breathing (SDB), specifically, obstructive sleep apnea, is associated with poorer glucose in the existing type 2 diabetic condition. In an exploration of this hypothesis, the investigators hope to provide evidence linking SDB to increased severity of disease in the type 2 diabetic patient. By doing so, the investigators ultimately seek to support investigating the use of SDB interventions as an additional method of care in the treatment of type 2 diabetes.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
The University of Chicago
Chicago, Illinois, United States
Start Date
February 1, 2007
Primary Completion Date
November 1, 2008
Completion Date
December 1, 2009
Last Updated
September 5, 2013
105
ACTUAL participants
Lead Sponsor
University of Chicago
NCT06430957
NCT07051005
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions